Tobias Ruck Selected Research

Tobias Ruck Research Topics

Disease

38	Multiple Sclerosis 01/2024 - 07/2014
14	Relapsing-Remitting Multiple Sclerosis 01/2023 - 07/2015
11	Myasthenia Gravis 04/2024 - 01/2019
10	Neuroinflammatory Diseases 01/2023 - 07/2014
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2022 - 03/2011
7	Myositis (Idiopathic Inflammatory Myopathies) 01/2024 - 08/2010
7	Inflammation (Inflammations) 01/2023 - 08/2014
5	Disease Progression 03/2024 - 01/2022
5	Infections 08/2022 - 07/2018
5	Deglutition Disorders (Dysphagia) 01/2021 - 01/2019
4	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 07/2014
4	Lymphopenia (Lymphocytopenia) 01/2023 - 01/2016
4	Encephalomyelitis (Myeloencephalitis) 11/2022 - 07/2014
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 10/2023 - 01/2022
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2018
3	COVID-19 01/2022 - 06/2020
2	Muscular Atrophy (Muscle Atrophy) 04/2024 - 08/2021
2	Muscle Weakness 03/2024 - 08/2021
2	Neuromuscular Diseases (Neuromuscular Disease) 01/2024 - 10/2023
2	Neoplasms (Cancer) 01/2024 - 07/2020
2	Polyneuropathies (Polyneuropathy) 10/2023 - 01/2022
2	Guillain-Barre Syndrome 10/2023 - 01/2019
2	Paralysis (Palsy) 10/2023 - 03/2011
2	Stroke (Strokes) 01/2023 - 01/2017
2	Inclusion Body Myositis 10/2022 - 01/2022
2	Dermatomyositis (Dermatopolymyositis) 10/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 02/2022 - 01/2021
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2020
2	Exanthema (Rash) 08/2021 - 01/2021
2	Rheumatoid Arthritis 05/2021 - 07/2015
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 09/2013
2	Cognitive Dysfunction 01/2017 - 01/2017
2	Polymyositis 12/2015 - 03/2015
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 05/2024
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 03/2024
1	Myocarditis (Carditis) 01/2024
1	Cardiomyopathies (Cardiomyopathy) 06/2023
1	Muscular Dystrophies (Muscular Dystrophy) 06/2023
1	Myotonic Dystrophy (Dystrophia Myotonica) 06/2023
1	Fibrosis (Cirrhosis) 06/2023
1	Medically Unexplained Symptoms 01/2023
1	Human Influenza (Influenza) 01/2023
1	Gliosis 01/2023
1	Glioma (Gliomas) 01/2023
1	Chronic Progressive Multiple Sclerosis 11/2022
1	Muscular Diseases (Myopathy) 11/2022
1	Absence Epilepsy (Childhood Absence Epilepsy) 10/2022

Drug/Important Bio-Agent (IBA)

19	Alemtuzumab (Campath)FDA Link 01/2023 - 03/2015
8	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2011
7	AntibodiesIBA 03/2024 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
6	AutoantibodiesIBA 01/2023 - 01/2019
6	Cladribine FDA LinkGeneric 01/2023 - 01/2021
4	Complement System Proteins (Complement)IBA 03/2024 - 10/2023
4	CytokinesIBA 10/2022 - 07/2014
3	Cholinergic ReceptorsIBA 04/2024 - 01/2019
3	Peptides (Polypeptides)IBA 10/2023 - 09/2013
3	Neuroprotective AgentsIBA 11/2022 - 01/2018
3	Ligases (Synthetase)IBA 10/2022 - 01/2021
3	ocrelizumabIBA 01/2022 - 01/2021
2	InterferonsIBA 03/2024 - 12/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 08/2023 - 08/2021
2	Ion Channels (Ion Channel)IBA 01/2023 - 05/2021
2	LigandsIBA 01/2023 - 12/2015
2	siponimodIBA 11/2022 - 11/2019
2	CuprizoneIBA 10/2022 - 01/2021
2	CalciumIBA 01/2022 - 12/2017
2	eculizumab FDA Link 01/2022 - 01/2021
2	Potassium Channels (Potassium Channel)IBA 01/2022 - 07/2015
2	Immunoglobulin G (IgG)IBA 06/2020 - 01/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 11/2019 - 01/2016
2	Monoclonal AntibodiesIBA 01/2019 - 07/2015
2	Natalizumab (Tysabri)FDA Link 01/2019 - 01/2017
2	Substance PIBA 01/2019 - 01/2017
1	nusinersenIBA 05/2024
1	ravulizumabIBA 04/2024
1	glucose-mannose-glucoseIBA 04/2024
1	Recombinant ProteinsIBA 03/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2023
1	3' Untranslated Regions (3' UTR)IBA 06/2023
1	PeriostinIBA 06/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2023
1	AntigensIBA 01/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023
1	muskIBA 01/2023
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2023
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2023
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 10/2022
1	Tryptophan (L-Tryptophan)FDA Link 09/2022

Therapy/Procedure

22	Therapeutics 03/2024 - 07/2015
3	Immunotherapy 01/2022 - 06/2020
2	Blood Component Removal (Apheresis) 10/2019 - 01/2017
1	Activities of Daily Living (ADL) 04/2024
1	Thymectomy 06/2023
1	Duration of Therapy 01/2023